HONOLULU - Attorney General Mark Bennett announced today that the State of Hawai'i has filed a complaint against McKesson Corporation and First DataBank, Inc., as part of an ongoing effort to recover for what the State believes were prescription drug overcharges to the State. The State's previous related lawsuit recovered (in total) more than $82 million from prescription drug manufacturers.
Louisiana Attorney General Buddy Caldwell has filed a lawsuit in East Baton Rouge Parish District Court alleging that 18 drug companies have ripped off state taxpayers by overcharging the Medicaid program. The suit says that the companies misreported their drug prices in a deliberate effort to increase the payments they receive from the Louisiana Medicaid system. Block Law Firm of Thibodaux and Beasley, Allen, Crow Methvin, Portis & Miles of Montgomery, Ala., signed the suit, along with Caldwell. Beasley Allen is among the nation's leading plaintiffs firms. Attorneys working on this case from Beasley Allen are W. Daniel Miles, III, head of the firm's Consumer Fraud Section, Roman Shaul, and Alison Douillard.
The State of Hawaii has reached a settlement agreement with pharmaceutical companies accused of defrauding the state's Medicaid system by overcharging for medications. The State will receive more than $82 million from a number of different drug companies involved in the litigation, which accused the companies of marketing and selling prescription drugs using fraudulent and inflated "average wholesale price" figures.
The following letter was sent to the Editor of every newspaper in Alabama by Beasley Allen Founding Shareholder Jere L. Beasley. The letter helps clarify the State of Alabama's position regarding the recent Supreme Court ruling on its Medicaid Fraud verdicts and pending litigation. This letter serves as a necessary and important counterpoint to previously published Letters to the Editor addressing the same subject.
Beasley Allen founding shareholder Jere L. Beasley speaks out on recent Alabama Supreme Court decision in state Medicaid Fraud lawsuits; asks Court to grant oral argument.
The Alabama Supreme Court refused the State of Alabama's request for oral argument in three of the most important cases to be heard by this Court in recent years.
In a shocking development, the Alabama Supreme Court reversed three of the State of Alabama's Medicaid fraud lawsuits that were on appeal. The court refused the state's multiple requests for oral argument in the cases, considered to be among the most important cases to be heard by this Court in recent years. To say the least, that was more than just unusual. The case against AstraZeneca, one of the defendants, had been on appeal for 13 months.
The Alabama Supreme Court apparently was not content to cheat the public with the outrageous ExxonMobil ruling. It pulled pretty much the same fraudulent stunt again the other day, with a few slight variations. In late 2007, the Alabama Supremes stunned many observers by overturning most of a $3.6 billion jury verdict in a fraud case against oil giant ExxonMobil. That decision robbed state coffers of badly needed funds at the outset of the Bush recession.
The Alabama Supreme Court on Friday threw out jury decisions awarding the state more than $274 million from three pharmaceutical companies, ruling they did not defraud the state in pricing Medicaid prescription drugs.
Today Alabama's Attorney General Troy King announced an additional $89 million in settlements in ongoing litigation against a total of 72 pharmaceutical companies accused of defrauding the state's Medicaid system by overcharging for drugs. Beasley Allen is representing the state in the Average Wholesale Price (AWP) litigation, and has already secured settlements totaling $34.75 million and jury verdicts of more than $352.4 million against pharmaceutical company defendants.
